Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 87650L103 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| Janus Henderson Group Ltd. 13G/A Amendment 1 | 6.5% |
8/13/2026
Event 6/30/2026
|
|
| Janus Henderson Group PLC 13G | 5.3% |
5/15/2026
Event 3/31/2026
|
|
|
Deep Track Capital, LP
13G/A
Amendment 2
|
8.5% |
5/15/2026
Event 3/31/2026
|
|
| Deep Track Capital, LP | 8.5% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 8.5% | ||
| David Kroin | 8.5% | ||
| Prudential Financial Inc 13G/A Amendment 20 | 4.3% |
5/8/2026
Event 3/31/2026
|
|
| Jennison Associates LLC 13G/A Amendment 1 | 4.0% |
5/6/2026
Event 3/31/2026
|
|
| Vanguard Group Inc 13G/A Amendment 2 | 0% |
3/27/2026
Event 3/13/2026
|
|
|
Tang Capital Management LLC
13G/A
Amendment 4
|
2.8% |
2/17/2026
Event 12/31/2025
|
|
| Tang Capital Management, LLC | 2.8% | ||
| Kevin Tang | 2.8% | ||
| Tang Capital Partners, LP | 0.8% | ||
| Tang Capital Partners International, LP | 1.9% | ||
| Tang Capital Partners III, Inc | 0.1% | ||
| Tang Capital Partners IV, Inc | <0.1% | ||
|
Deep Track Capital, LP
13G/A
Amendment 1
|
7.1% |
11/14/2025
Event 9/30/2025
|
|
| Deep Track Capital, LP | 7.1% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 7.1% | ||
| David Kroin | 7.1% | ||
|
RTW Investments, LP
13G/A
Amendment 5
|
8.1% |
8/14/2025
Event 6/30/2025
|
|
| RTW Investments, LP | 8.1% | ||
| Roderick Wong | 8.1% | ||
|
Deep Track Capital, LP
13G
|
5.6% |
7/28/2025
Event 7/21/2025
|
|
| Deep Track Capital, LP | 5.6% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 5.6% | ||
| David Kroin | 5.6% | ||
|
Tang Capital Management LLC
13G/A
Amendment 3
|
5.9% |
5/15/2025
Event 3/31/2025
|
|
| Tang Capital Management, LLC | 5.9% | ||
| Kevin Tang | 5.9% | ||
| Tang Capital Partners, LP | 5.6% | ||
| Tang Capital Partners International, LP | 0.2% | ||
| Tang Capital Partners III, Inc | 0.1% | ||
| Tang Capital Partners IV, Inc | <0.1% | ||
| Morgan Stanley 13G/A Amendment 1 | 4.7% |
5/7/2025
Event 3/31/2025
|
|
| BlackRock, Inc. 13G/A Amendment 2 | 7.4% |
4/24/2025
Event 3/31/2025
|
|
| Cowen Financial Products LLC 13G/A Amendment 2 | 4.9% |
2/13/2025
Event 12/31/2024
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 5 | 4.91 k | $386 k |
| 2026 Q2 | 271 | 50.6 M | $3.08 B |
| 2026 Q1 | 262 | 45.1 M | $3.17 B |
| 2025 Q4 | 253 | 44.1 M | $3.61 B |
| 2025 Q3 | 229 | 45.2 M | $2.69 B |
| 2025 Q2 | 211 | 48.0 M | $1.95 B |
| 2025 Q1 | 203 | 44.0 M | $2.26 B |
| 2024 Q4 | 207 | 40.3 M | $2.23 B |
| 2024 Q3 | 174 | 43.9 M | $1.44 B |
| 2024 Q2 | 161 | 42.4 M | $1.15 B |
| 2024 Q1 | 175 | 44.3 M | $1.61 B |
| 2023 Q4 | 126 | 34.8 M | $705 M |
| 2023 Q3 | 110 | 29.8 M | $529 M |
| 2023 Q2 | 96 | 21.4 M | $387 M |
| 2023 Q1 | 79 | 20.1 M | $252 M |
| 2022 Q4 | 73 | 20.9 M | $306 M |
| 2022 Q3 | 78 | 20.5 M | $351 M |
| 2022 Q2 | 76 | 20.0 M | $292 M |
| 2022 Q1 | 52 | 13.2 M | $222 M |
| 2021 Q4 | 45 | 14.4 M | $323 M |
| 2021 Q3 | 45 | 12.9 M | $277 M |
| 2021 Q2 | 46 | 14.4 M | $416 M |
| 2021 Q1 | 43 | 14.1 M | $451 M |
| 2020 Q4 | 41 | 12.8 M | $524 M |